ArticleCancers2025
Computed Tomography of Neoplastic Infiltrating Renal Masses in Patients Without a Previous History of Cancer.
Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesInfiltrative renal masses, characterized by ill-defined margins and parenchymal invasion without forming a discrete mass, present a diagnostic challenge, particularly in patients without a prior history of malignancy. Differentiating among the most common malignant etiologies-renal cell carcinoma (RCC), urothelial carcinoma (UC), and lymphoma-is essential for guiding appropriate treatment. This study aimed to evaluate whether specific computed tomography (CT) features can assist in the differential diagnosis of these lesions.
methodsA retrospective review was conducted on 68 patients with infiltrative renal masses presented at a tertiary hospital's oncologic urology committee between 2018 and 2022. Patients with prior malignancy or signs of infection were excluded. All cases underwent contrast-enhanced CT within three months of diagnosis and had histopathological confirmation. Imaging features such as necrosis, collecting system involvement, lymphadenopathy, and others were assessed and statistically analyzed.
resultsRCC was the most frequent diagnosis (68%), followed by UC (18%) and lymphoma (7.4%). Significant differences were observed in imaging features: necrosis was more common in RCC (87%) than in UC (25%) and lymphoma (20%),
conclusionsCT imaging features, particularly necrosis, collecting system involvement, and lymphadenopathy, can aid in distinguishing among RCC, UC, and lymphoma in patients with infiltrative renal masses and no prior cancer history. These findings may support more accurate diagnoses and inform tailored therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.